· Published by Health Canada · Official notice
Apotex Inc. is recalling one lot (lot RF0410, expiry 05/2024) because of a nitrosamine impurity.
APO-Amitriptyline 10 mg tablets, DIN 02403137
Patients can continue to take their medication as prescribed by their health care provider as there is no immediate risk in continuing to take the recalled medication. Contact your health care provider if you have taken a recalled product and you have concerns about your health.
| Company | Product | Strength | DIN | Lot | Expiry |
|---|---|---|---|---|---|
| Apotex Inc. | APO-Amitriptyline (Amitriptyline Hydrochloride Tablets USP) |
10 mg | 02403137 | RF0410 | 05/2024 |